Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Morton

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing programHernan Carol, Richard Lock, Peter J Houghton, et al.
Plos One|February 15, 2013
Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activityW Shannon Orr, Jason W Denbo, Karim R Saab, et al.
Pediatric Blood & Cancer|February 9, 2008
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, Doris A Phelps, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Lock, et al.
Journal of Molecular Biology|August 6, 2005
Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzilChristopher D Fleming, Sompop Bencharit, Carol C Edwards, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Pediatric Blood & Cancer|July 20, 2007
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Human Gene Therapy|February 29, 2024
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene TransferMark A Brimble, Christopher L Morton, Stephen M Winston, et al.
Cancer Research|September 5, 2002
Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patientsLars M Wagner, Sylvie M Guichard, Rebecca A Burger, et al.
Pediatric Blood & Cancer|June 8, 2007
Initial testing of cisplatin by the pediatric preclinical testing programMimi Tajbakhsh, Peter J Houghton, Christopher L Morton, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing programHernan Carol, Richard Lock, Peter J Houghton, et al.
Plos One|February 15, 2013
Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activityW Shannon Orr, Jason W Denbo, Karim R Saab, et al.
Pediatric Blood & Cancer|February 9, 2008
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, Doris A Phelps, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Lock, et al.
Journal of Molecular Biology|August 6, 2005
Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzilChristopher D Fleming, Sompop Bencharit, Carol C Edwards, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Pediatric Blood & Cancer|July 20, 2007
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Human Gene Therapy|February 29, 2024
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene TransferMark A Brimble, Christopher L Morton, Stephen M Winston, et al.
Cancer Research|September 5, 2002
Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patientsLars M Wagner, Sylvie M Guichard, Rebecca A Burger, et al.
Pediatric Blood & Cancer|June 8, 2007
Initial testing of cisplatin by the pediatric preclinical testing programMimi Tajbakhsh, Peter J Houghton, Christopher L Morton, et al.
Pageof 10